... pipeline of more than 70 human antibody drug candidates for the treatment of cancer, rheumatoid arthritis, and Alzheimer's disease, to name just a few. With its ongoing commitment to new antibody technology and drug development, MorphoSys is focused ...
http://www.pr-inside.com/morphosys-ag-announcement-of-the-convening-of-the--r3640145.htm
http://www.pr-inside.com/morphosys-ag-announcement-of-the-convening-of-the--r3640145.htm
No comments:
Post a Comment